According to the last report, OCC was calling the CE Mark before the end of the year. It is likely to be only weeks away. One would think that this unnamed Swiss group should not be able to influence an independent body, but when it comes to money, there's always plenty of cloak and dagger it seems. Orthocell's products appear to have an edge over most if not all competitor offerings and so would be seen as an enormous threat. Their stem cell technology is a significant moat.
According to the last report, OCC was calling the CE Mark before...
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.005(1.27%) |
Mkt cap ! $81.63M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 39.5¢ | 38.5¢ | $29.16K | 75.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 75123 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 37896 | 2 |
View Market Depth
| Last trade - 14.32pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
39.0¢ |
Change
-0.005 ( 1.27 %) |
||||
| Open | High | Low | Volume | ||
| 38.5¢ | 39.0¢ | 38.5¢ | 25594 | ||
| Last updated 14.32pm 06/05/2024 ? | |||||
| OCC (ASX) Chart |